Where others have failed will Atl1102 succeed ?, page-454

Hey guys, apologies for the formatting in the following. Playing monster trucks with my youngest, realised it may be of interest, so just pasting a text I sent to a mate yesterday:

My personal guess/take is that the announcement reeks of Pfizer. Specifically, the CRO. I'm drawing a bit of a long bow here, but a few points:

Firstly, I think (guessing) Parexel are too expensive for us.

Secondly, Parexel has had a decade long partnership with Pfizer: https://bit.ly/3mdNAEP

Finally, when Sarepta's DMD drug was approved, a Ronald Farkas quit the FDA quit and went to Parexel: https://bit.ly/3zY6yV1

i.e. If we were hoping to get into bed with Sarepta, this CRO would be an interesting choice.

Also worth looking at their experience in running trials across the US/EU. I'm excited!